Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Immunol Methods ; 439: 44-49, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27693389

RESUMEN

Calprotectin, a heterodimer of S100A8 and S100A9, has been reported to be a useful biomarker in inflammatory bowel disease (IBD); however, the relationship between the fecal level of S100A9 and the extent of inflammation in IBD remains unclear. Our aim was to develop a new enzyme-linked immunosorbent assay (ELISA) for rat S100A9, and to investigate whether changes in fecal S100A9 levels reflect the inflammatory conditions in the intestinal tracts of rats with dextran sulfate sodium (DSS)-induced colitis. Anti-rat S100A9 monoclonal antibodies were raised in mice and used for the development of a novel ELISA for rat S100A9. The performance of our ELISA was assessed by dilution and recovery tests, and the detection range was 3.75-240ng/mL. The dilution test showed good linearity. The recovery of fecal S100A9 was 95.1% (mean), with a range of 86.1%-108.8%. Colitis was induced in rats by oral administration of 3% DSS/drinking water (DW) for 11days (D group), while DW alone was provided to rats of the control group (C group) during the same period. The extent of inflammation was evaluated with the disease activity index (DAI), and the concentration of fecal S100A9 was determined by ELISA. Both the DAI scores and the fecal S100A9 levels were significantly higher in the D group than in the C group. Microscopic observation revealed that S100A9 was dominantly produced in many immune cells of myeloid origin in rat rectal tissues. These results indicate that the novel ELISA may be applied to clinically evaluate IBD in rats with high sensitivity. In conclusion, our ELISA is useful in toxicological and pharmacological evaluations.


Asunto(s)
Calgranulina B/metabolismo , Colitis/metabolismo , Colon/metabolismo , Sulfato de Dextran , Ensayo de Inmunoadsorción Enzimática , Heces/química , Animales , Anticuerpos Monoclonales/inmunología , Biomarcadores/metabolismo , Calgranulina B/inmunología , Colitis/inducido químicamente , Colitis/inmunología , Colitis/patología , Colon/inmunología , Colon/patología , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Diagnóstico Precoz , Femenino , Masculino , Valor Predictivo de las Pruebas , Ratas Endogámicas F344 , Ratas Sprague-Dawley , Factores de Tiempo
2.
Int J Cardiol ; 97(3): 577-8, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15561356

RESUMEN

Giant sacclar aneurysm in a coronary-pulmonary artery fistula is extremely rare. In this article, we presented two cases of giant aneurysms in coronary-pulmonary artery fistula with atherosclerosis.


Asunto(s)
Arteriosclerosis/fisiopatología , Anciano , Fístula Arteriovenosa/complicaciones , Aneurisma Coronario/complicaciones , Femenino , Humanos , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA